# Guangzhou Nan Yue Fund

> Guangzhou Nan Yue Fund is a VC fund in Guangzhou backing Health Care, B2B and Travel. See 6 investments, round sizes, portfolio. Updated Oct 2026.

- Type: VC Fund
- Location: Guangzhou, China
- Total investments: 6
- Last investment: Apr 2025
- Lead investor: 17%
- Last updated: Oct 2026
- Website: http://www.gznyjj.com/index.aspx

Guangzhou Nan Yue Fund is a VC fund in Guangzhou focused on Health Care and B2B. Guangzhou Nan Yue Fund

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 33% |
| B2B | 1 | 17% |
| Travel | 1 | 17% |
| Battery | 1 | 17% |
| Medical | 1 | 17% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 2 | 33% |
| Series B | 2 | 33% |
| Private Equity | 1 | 17% |
| Venture - Series Unknown | 1 | 17% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| YoYoung | YoYoung is a veterinary testing service provider that specializes in the research, development, and sales of in vitro diagnostic products. |  | Series A | Apr 08, 2025 | http://www.yy-bio.com/ |
| Wanxietong Information Technology | Wanxietong Information Technology is a national high-tech company that provides integrated circuit design and chip-level solutions. | $13.7M | Venture - Series Unknown | Oct 12, 2023 | https://www.wisectech.com.cn |
| Libao | Libao New Material produces and conducts research on precursors and materials for lithium (sodium) cathodes. | $265.6M | Series B | Apr 12, 2023 | http://www.libode.com.cn/ |
| Juwan Technology | Juwan Technology Research Institute is the first in-house incubation technology innovation company of GAC Group. | $157.2M | Series A | Apr 01, 2022 | http://www.gbtrnd.com/ |
| Doublle Bioproduct | Doublle Bioproduct focuses on the research and development of anti-tumor drugs. Doublle Bioproduct has established five new drug research and development functional platforms, including Gene therapy drug industrial production and quality control platform, cell biotherapy research and development and application platform, tumor vaccine and specificimmunotherapy product platform, anti-tumor leading macromolecular drug candidate construction, and pharmacodynamics platform. |  | Private Equity | Sep 25, 2021 | http://www.gzdoublle.com |
| lvyouquan | Lvyouquan initially focused on providing marketing and sales services | $78M | Series B | Nov 23, 2015 | http://www.lvyouquan.cn/ |

6 of 6 investments shown.

## Co-investors
- [Borun Capital](https://shizune.co/investors/profile/borun-capital) — VC Fund, 1 deal together
- [China Securities](https://shizune.co/investors/profile/china-securities) — VC Fund, 1 deal together
- [CICC](https://shizune.co/investors/profile/cicc) — VC Fund, 1 deal together
- [E-House](https://shizune.co/investors/profile/e-house) — VC Fund, 1 deal together
- Farasis Energy (GanZhou) — VC Fund, 1 deal together
- [GAC Capital](https://shizune.co/investors/profile/gac-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does Guangzhou Nan Yue Fund invest in?

Guangzhou Nan Yue Fund invests primarily in Health Care, B2B and Travel startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Guangzhou Nan Yue Fund last invest?

The most recent investment recorded for Guangzhou Nan Yue Fund closed in Apr 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co